| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 11/13/2013 | CN102603910B Preparation method of pachyman sulfate |
| 11/13/2013 | CN102579407B Preparation method for indapamide microsphere sustained release capsules |
| 11/13/2013 | CN102552722B Traditional Chinese medicinal preparation for stopping bleeding and disinfecting |
| 11/13/2013 | CN102526057B Quinazoline derivative as pgk1 (phosphoglycerate kinase 1) activator |
| 11/13/2013 | CN102512647B Chinese herbal composition for treating abdominal pain due to deficiency-cold |
| 11/13/2013 | CN102512627B Traditional Chinese medicine composition for postoperative lung cancer |
| 11/13/2013 | CN102396950B Health-care and health-promotion pillow |
| 11/13/2013 | CN102133194B Preparation method and application of tanshinone II A solid dispersion pellets |
| 11/13/2013 | CN102076699B Hydrogensulfate salt of 2-acetoxy-5-(alpha-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine and preparation thereof |
| 11/13/2013 | CN101947368B Flame-retardant body strengthening safety clothing of nano-element fiber fabric |
| 11/13/2013 | CN101904848B Use of HIF alpha stabilizers for enhancing erythropoiesis |
| 11/13/2013 | CN101684124B Novel compound with blood coagulation resisting function |
| 11/13/2013 | CN101472879B Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof |
| 11/12/2013 | US8580777 Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa |
| 11/12/2013 | US8580743 Modified galectin 9 proteins and methods of treatment using them |
| 11/12/2013 | US8580737 Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates |
| 11/12/2013 | US8580732 Peptide therapy for hyperglycemia |
| 11/12/2013 | US8580563 Placental stem cells |
| 11/12/2013 | CA2708418C Oxazolidinones for the treatment and/or prophylaxis of heart failure |
| 11/12/2013 | CA2614639C Pharmaceutical composition for treatment of blood clotting disorder |
| 11/12/2013 | CA2606851C Composition and method for treating nosebleeds |
| 11/12/2013 | CA2510823C Hemostatic compositions and devices |
| 11/12/2013 | CA2448022C Compositions for protein delivery via the pulmonary route |
| 11/12/2013 | CA2296071C Production and use of recombinant protein multimers with altered biological activity |
| 11/07/2013 | WO2003033664A9 Bone anti-resorptive compounds |
| 11/07/2013 | US20130296985 Indwelling heat exchange catheter and method of using same |
| 11/07/2013 | US20130295151 Process for the treatment of cellulosic molded bodies |
| 11/07/2013 | US20130295009 Method of treating inflammation |
| 11/06/2013 | EP2658851A1 Heterocyclic compounds suitable for the treatment of dyslipidemia |
| 11/06/2013 | EP2658580A1 Arginase inhibitors and methods of use thereof |
| 11/06/2013 | CN103382463A Ocean Sipunculus nudus plasmin and its preparation and application |
| 11/06/2013 | CN103382432A Ginseng and deer antler wine and preparation process |
| 11/06/2013 | CN103382430A Health care wine capable of invigorating blood circulation and enriching blood |
| 11/06/2013 | CN103382232A Preparation and purification process for nadroparin calcium |
| 11/06/2013 | CN103382216A Cyanoisoquinoline compounds and methods of use thereof |
| 11/06/2013 | CN103382201A Heteroaryl derivatives as cftr modulators |
| 11/06/2013 | CN103381267A Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 11/06/2013 | CN103381242A Traditional Chinese medicine for treating enuresis and preparation method thereof |
| 11/06/2013 | CN103381201A Application of fleece-flower root extract in preparation of antithrombotic medicines and health care products |
| 11/06/2013 | CN103381189A Porous hemostatic powder and its preparation method |
| 11/06/2013 | CN103381187A Application of Houttuynoid E in drug for resisting platelet aggregation |
| 11/06/2013 | CN103381175A Application of Houttuynoid B in drug for resisting platelet aggregation |
| 11/06/2013 | CN103381170A Applications of Chukrasone A in preparation of anti-platelet aggregation medicines |
| 11/06/2013 | CN103381158A Applications of Chukrasone B in medicines used for increasing thrombocyte |
| 11/06/2013 | CN103381151A Application of caffeic acid to prepare antithrombotic medicaments |
| 11/06/2013 | CN103381150A Pharmaceutical composition and application thereof |
| 11/06/2013 | CN103381142A Ginsenoside Rh1 self-microemulsion composition, and preparation method and application thereof |
| 11/06/2013 | CN102973501B Tranexamic acid injection and preparation method of same |
| 11/06/2013 | CN102895643B Composition for tonifying qi, arresting sperm, nourishing qi, nourishing blood and strengthening waist and knees |
| 11/06/2013 | CN102793730B Ginkgo-damole medicinal composition and preparation method thereof |
| 11/06/2013 | CN102727771B Traditional Chinese drug decoction for treating colporrhagia after artificial abortion |
| 11/06/2013 | CN102727431B Injecta containing milrinone and preparation method thereof |
| 11/06/2013 | CN102716486B Slowly-releasing anticancer drug composition and application thereof |
| 11/06/2013 | CN102648970B Medicine composition for treating chronic aplastic anemia and preparation method thereof |
| 11/06/2013 | CN102552865B Traditional Chinese medicine composition for treating gestational edema |
| 11/06/2013 | CN102552736B Traditional Chinese medicine composition for treating idiopathic thrombocytopenic purpura |
| 11/06/2013 | CN102526561B Detection method for Sanjin preparation |
| 11/06/2013 | CN102526487B Chinese medicament for treating immune thrombocytopenic purpura |
| 11/06/2013 | CN102525895B Norepinephrine bitartrate injection and preparation process thereof |
| 11/06/2013 | CN102429929B Compound fermented cordyceps fungus powder and taurine combined drug |
| 11/06/2013 | CN102369197B 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines used as ADP receptor antagonists |
| 11/06/2013 | CN102212001B Compound salvianolic acid F methyl ester and preparation method thereof |
| 11/06/2013 | CN102056923B New co-crystal compound of rivaroxaban and malonic acid |
| 11/06/2013 | CN102000125B Ginkgo flavone extraction method |
| 11/06/2013 | CN101912394B Medicinal composition for treating coagulopathy haemorrhage and application thereof |
| 11/06/2013 | CN101857550B Method for producing 6-aminocaproic acid hydrochloride and 6-aminocaproic acid by using nylon-6 waste through depolymerization |
| 11/06/2013 | CN101534904B BCL inhibitors treating platelet excess |
| 11/06/2013 | CN101484391B Method for activating and stabilizing dissolved hydrogen in water |
| 11/06/2013 | CN101302515B Human antibodies that bind human TNF(alpha) |
| 11/06/2013 | CN101189334B 抗cd14抗体融合蛋白质 Anti-cd14 antibody fusion proteins |
| 11/05/2013 | US8575307 Protein kinase C inhibitors for prevention of insulin resistance and type 2 diabetes |
| 11/05/2013 | US8575204 Nicotinamide derivates useful as P38 inhibitors |
| 11/05/2013 | US8575167 Spiro compounds having stearoyl-CoA desaturase action |
| 11/05/2013 | US8575103 Peptides and methods for inhibiting G alpha protein signaling |
| 11/05/2013 | CA2491994C Modulators of the glucocorticoid receptor |
| 11/05/2013 | CA2462512C Use of collagenase to facilitate guide wire crossing in total arterial occlusions |
| 10/31/2013 | WO2013163279A1 Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation |
| 10/31/2013 | WO2013163244A1 Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation |
| 10/31/2013 | WO2013163241A1 Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation |
| 10/31/2013 | WO2013162078A1 Therapeutic agent for injury in epithelium and endothelium |
| 10/31/2013 | WO2013160005A1 Pharmaceutical composition suitable for treatment of haemophilia |
| 10/31/2013 | WO2013159412A1 Method for extracting and separating ginkgolides |
| 10/31/2013 | WO2013159411A1 Ginkgolide injection and preparation method thereof |
| 10/31/2013 | WO2013159188A1 Polymer-based dialysate |
| 10/31/2013 | WO2013159166A1 Pharmaceutical oral dosage form for preventing vascular diseases, tablet as pharmaceutical dosage form and gelatin capsule as pharmaceutical dosage form |
| 10/31/2013 | WO2013043085A8 (rs)-2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide compound which exhibits modulatory activity with a commensurate effect, pharmaceutical substance (variants) and use thereof, composition (variants) |
| 10/31/2013 | WO2003023014A9 Human ion channels |
| 10/31/2013 | WO2002064559A3 Thrombin inhibitors |
| 10/31/2013 | US20130288999 Compositions and methods for modulation of vascular structure and/or function |
| 10/30/2013 | EP2657241A1 Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient |
| 10/30/2013 | EP2656851A1 Semuloparin for improving the survival of patients with cancer |
| 10/30/2013 | EP2656850A2 Oligonucleotides for the treatment or alleviation of edema |
| 10/30/2013 | EP2656845A1 Composition for modulating stem cell growth with prostaglandins |
| 10/30/2013 | EP2655399A1 Trypsin-like serine protease inhibitors, their preparation and use as selective inhibitors of the clotting factors iia and xa |
| 10/30/2013 | EP2655375A1 Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof |
| 10/30/2013 | EP2654794A1 Materials and methods for conjugating a water soluble fatty acid derivative to a protein |
| 10/30/2013 | EP2654764A1 Hemostatic preparation containing an extract of golden moss |
| 10/30/2013 | CN103380108A Palladium-copper catalysts for the homogeneous selective oxidation of thiol groups |
| 10/30/2013 | CN103374073A Human derived monoclonal antibody for identifying activated integrin alpha 4 beta 7 |
| 10/30/2013 | CN103373939A 4-methoxy-N, N'-bisubstituted phenyl-1, 3-benzene diamide compounds as well as preparation method and application thereof |